seen from Romania
seen from Germany
seen from Singapore
seen from Romania
seen from Netherlands
seen from Netherlands
seen from Netherlands
seen from Netherlands
seen from Netherlands
seen from United States
seen from Netherlands
seen from Netherlands
seen from United States
seen from China
seen from Azerbaijan
seen from United States
seen from Singapore
seen from United States
seen from Netherlands
seen from Singapore
I was at a bar this week with friends, and this guy comes up to me and asks me if I'm alright because he saw me typing a wall of text, and he thought I was like upset at a boyfriend or something. I then had to explain to him that I had just opened Google Drive on my phone and was designing amino acid assays.
Imo these kiddos gonna BS their term paper and as someone who has BSed many a term paper myself, I completely agree
Plying potency assays for immunotherapy of solid tumors - Research
Front Immunol. 2026 Mar 24;17:1770222. doi: 10.3389/fimmu.2026.1770222. eCollection 2026. ABSTRACT Potency assays for cellular immunotherapies have advanced considerably yet remain only partially aligned with the complex requirements of solid tumors, where trafficking, persistence, metabolic fitness and spatially constrained effector function are key determinants of in vivo performance. Critical…
Beyond the Bottleneck: Engineering Sensitive Bespoke MRD Assays
This webinar, brought to you by Twist Bioscience, will be hosted live and available on-demand. Monday, April 13th, 202611:00 AM – 12:00 PM ET Tumor-informed liquid biopsy stands as the gold standard for monitoring minimal residual disease (MRD), but scientists face significant hurdles in assay development and adoption. Operational complexity, workflow bottlenecks, and the need to deliver highly…
Diagnostic Concordance of Two- and Three-Gene SARS-CoV-2 Molecular Assays in Cameroon: Implications for Efficient Pandemic Response in Low- and Middle-Income Countries - Research
Background: The scale-up of molecular assays for diagnosing emerging pathogens has increased in low-and-middle-income countries (LMICs) since the advent of COVID-19. We herein evaluated the diagnostic concordance of three different assays for SARS-CoV-2 in Cameroon. Methods: A laboratory-based comparative study was performed on nasopharyngeal samples collected between March-2020 to March-2023…
Diagnostic Concordance of Two- and Three-Gene SARS-CoV-2 Molecular Assays in Cameroon: Implications for Efficient Pandemic Response in Low- and Middle-Income Countries - Research
Background: The scale-up of molecular assays for diagnosing emerging pathogens has increased in low-and-middle-income countries (LMICs) since the advent of COVID-19. We herein evaluated the diagnostic concordance of three different assays for SARS-CoV-2 in Cameroon. Methods: A laboratory-based comparative study was performed on nasopharyngeal samples collected between March-2020 to March-2023…
Diagnostic Concordance of Two- and Three-Gene SARS-CoV-2 Molecular Assays in Cameroon: Implications for Efficient Pandemic Response in Low- and Middle-Income Countries - Research
Background: The scale-up of molecular assays for diagnosing emerging pathogens has increased in low-and-middle-income countries (LMICs) since the advent of COVID-19. We herein evaluated the diagnostic concordance of three different assays for SARS-CoV-2 in Cameroon. Methods: A laboratory-based comparative study was performed on nasopharyngeal samples collected between March-2020 to March-2023…
Comparative analysis of three different serum-free light chain assays in the diagnosis of multiple myeloma - Research
Background: The lack of analysis methods and standardization are the core problems of serum free light chain (sFLC) detection in Multiple myeloma (MM). This study validated a new KHB sFLC assay through comparative analysis with conventional assays. Materials and methods: Serum samples from 97 hospitalized MM patients were continuously collected. KHB, Freelite and N Latex assays were used to…
